SEARCH

SEARCH BY CITATION

References

  • Adan R. A., Van Leeuwen F. W., Sonnemans M. A., Brouns M., Hoffman G., Verbalis J. G. and Burbach J. P. (1995) Rat oxytocin receptor in brain, pituitary, mammary gland, and uterus: partial sequence and immunocytochemical localization. Endocrinology 136, 40224028.
  • Asherson P., Mant R., Williams N. et al. (1998) A study of chromosome 4p markers and dopamine D5 receptor gene in schizophrenia and bipolar disorder. Mol. Psychiatry 3, 310320.
  • Björkhem I. (2002) Do oxysterols control cholesterol homeostasis? J. Clin. Invest. 110, 725730.
  • Björkhem I. and Diczfalusy U. (2002) Oxysterols: friends, foes, or just fellow passengers? Arterioscler. Thromb. Vasc. Biol. 22, 734742.
  • Björkhem I. and Meaney S. (2004) Brain cholesterol: long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol. 24, 806815.
  • Bonini J. A., Jones K. A., Adham N. et al. (2000) Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J. Biol. Chem. 275, 3932439331.
  • Breton C., Chellil H., Kabbaj-Benmansour M. et al. (2001) Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist: comparison with the human V1a vasopressin receptor. J. Biol. Chem. 276, 2693126941.
  • Brown A. J. and Jessup W. (1999) Oxysterols and atherosclerosis. Atherosclerosis 142, 128.
  • Brown A. J. and Jessup W. (2009) Oxysterols: sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis. Mol. Aspects Med. 30, 111122.
  • Cheng D., Jenner A. M., Shui G. et al. (2011) Lipid pathway alterations in Parkinson's disease primary visual cortex. PLoS ONE 6, e17299.
  • Christoforou A., Le Hellard S., Thomson P. A. et al. (2007) Association analysis of the chromosome 4p15-p16 candidate region for bipolar disorder and schizophrenia. Mol. Psychiatry 12, 10111025.
  • Colles S. M., Maxson J. M., Carlson S. G. and Chisolm G. M. (2001) Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols. Trends Cardiovasc. Med. 11, 131138.
  • Collins S., Caron M. G. and Lefkowitz R. J. (1991) Regulation of adrenergic receptor responsiveness through modulation of receptor gene expression. Annu. Rev. Physiol. 53, 497508.
  • Edwards F. A. (1995) Anatomy and electrophysiology of fast central synapses lead to a structural model for long-term potentiation. Physiol. Rev. 75, 759787.
  • Edwards P. A. Kennedy M. A. and Mak P. A. (2002) LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis. Vascul. Pharmacol. 38, 249256.
  • Elshourbagy N. A., Ames R. S., Fitzgerald L. R. et al. (2000) Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J. Biol. Chem. 275, 2596525971.
  • Erraji-Benchekroun L., Underwood M. D., Arango V., Galfalvy H., Pavlidis P., Smyrniotopoulos P., Mann J. J. and Sibille E. (2005) Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol. Psychiatry 57, 549558.
  • Gahete M. D., Rubio A., Cordoba-Chacon J., Gracia-Navarro F., Kineman R. D., Avila J., Luque R. M. and Castano J. P. (2010) Expression of the ghrelin and neurotensin systems is altered in the temporal lobe of Alzheimer's disease patients. J. Alzheimers Dis. 22, 819828.
  • Gargiulo S., Sottero B., Gamba P., Chiarpotto E., Poli G. and Leonarduzzi G. (2011) Plaque oxysterols induce unbalanced up-regulation of matrix metalloproteinase-9 in macrophagic cells through redox-sensitive signaling pathways: implications regarding the vulnerability of atherosclerotic lesions. Free Radic. Biol. Med. 51, 844855.
  • Gramajo A. L., Zacharias L. C., Neekhra A., Luthra S., Atilano S. R., Chwa M., Brown D. J., Kuppermann B. D. and Kenney M. C. (2010) Mitochondrial DNA damage induced by 7-ketocholesterol in human retinal pigment epithelial cells in vitro. Invest. Ophthalmol. Vis. Sci. 51, 11641170.
  • Gregory S. G., Connelly J. J., Towers A. J. et al. (2009) Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Med. 7, 62.
  • Guardiola F., Dutta P. C., Codony R. and Savage G. P. (2002) Cholesterol and Phytosterol Oxidation Products: Analysis, Occurrence, and Biological Effects. AOCS Press, Champaign.
  • He X., Jenner A. M., Ong W. Y., Farooqui A. A. and Patel S. C. (2006) Lovastatin modulates increased cholesterol and oxysterol levels and has a neuroprotective effect on rat hippocampal neurons after kainate injury. J. Neuropathol. Exp. Neurol. 65, 652663.
  • Heinrichs M., Baumgartner T., Kirschbaum C. and Ehlert U. (2003) Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol. Psychiatry 54, 13891398.
  • Hökfelt T., Rehfeld J. F., Skirboll L., Ivemark B., Goldstein M. and Markey K. (1980) Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature 285, 476478.
  • Hollander E., Bartz J., Chaplin W., Phillips A., Sumner J., Soorya L., Anagnostou E. and Wasserman S. (2007) Oxytocin increases retention of social cognition in autism. Biol. Psychiatry 61, 498503.
  • Jusakul A., Yongvanit P., Loilome W., Namwat N. and Kuver R. (2011) Mechanisms of oxysterol-induced carcinogenesis. Lipids Health Dis. 10, 44.
  • Kim J. H., Jittiwat J., Ong W. Y., Farooqui A. A. and Jenner A. M. (2010) Changes in cholesterol biosynthetic and transport pathways after excitotoxicity. J. Neurochem. 112, 3441.
  • Kim J. H., Ee S. M., Jittiwat J., Ong E. S., Farooqui A. A., Jenner A. M. and Ong W. Y. (2011) Increased expression of acyl-coenzyme A: cholesterol acyltransferase-1 and elevated cholesteryl esters in the hippocampus after excitotoxic injury. Neuroscience 185, 125134.
  • Kimura T., Makino Y., Bathgate R. et al. (1997) The role of N-terminal glycosylation in the human oxytocin receptor. Mol. Hum. Reprod. 3, 957963.
  • Kirsch P., Esslinger C., Chen Q. et al. (2005) Oxytocin modulates neural circuitry for social cognition and fear in humans. J. Neurosci. 25, 1148911493.
  • Koefoed P., Hansen T. V., Woldbye D. P. et al. (2009) An intron 1 polymorphism in the cholecystokinin-A receptor gene associated with schizophrenia in males. Acta Psychiatr. Scand. 120, 281287.
  • Kojro E., Hackenberg M., Zsigo J. and Fahrenholz F. (1991) Identification and enzymatic deglycosylation of the myometrial oxytocin receptor using a radioiodinated photoreactive antagonist. J. Biol. Chem. 266, 2141621421.
  • Kosaka H., Munesue T., Ishitobi M., Asano M., Omori M., Sato M., Tomoda A. and Wada Y. (2012) Long-term oxytocin administration improves social behaviors in a girl with autistic disorder. BMC Psychiatry 12, 110.
  • Kosfeld M., Heinrichs M., Zak P. J., Fischbacher U. and Fehr E. (2005) Oxytocin increases trust in humans. Nature 435, 673676.
  • Landgraf R. and Neumann I. D. (2004) Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front. Neuroendocrinol. 25, 150176.
  • Lee H. J., Caldwell H. K., Macbeth A. H., Tolu S. G. and Young W. S., III (2008) A conditional knockout mouse line of the oxytocin receptor. Endocrinology 149, 32563263.
  • Leoni V. (2009) Oxysterols as markers of neurological disease-a review. Scand. J. Clin. Lab. Invest. 69, 2225.
  • Leoni V. and Caccia C. (2011) Oxysterols as biomarkers in neurodegenerative diseases. Chem. Phys. Lipids 164, 515524.
  • Li X. M., Hedlund P. B. and Fuxe K. (1995) Cholecystokinin octapeptide in vitro and ex vivo strongly modulates striatal dopamine D2 receptors in rat forebrain sections. Eur. J. Neurosci. 7, 962971.
  • Li J., Chen C., He Q., Li H., Moyzis R. K., Xue G. and Dong Q. (2011) Neurotensin receptor 1 gene (NTSR1) polymorphism is associated with working memory. PLoS ONE 6, e17365.
  • Liu Q., Guan X. M., Martin W. J. et al. (2001) Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J. Biol. Chem. 276, 3696136969.
  • Liu H., Yuan L., Xu S., Wang K. and Zhang T. (2005) Cholestane-3beta,5alpha,6beta-triol inhibits osteoblastic differentiation and promotes apoptosis of rat bone marrow stromal cells. J. Cell. Biochem. 96, 198208.
  • Lütjohann D., Papassotiropoulos A., Björkhem I. et al. (2000) Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J. Lipid Res. 41, 195198.
  • Ma M. T., Zhang J., Farooqui A. A., Chen P. and Ong W. Y. (2010) Effects of cholesterol oxidation products on exocytosis. Neurosci. Lett. 476, 3641.
  • Malvitte L., Montange T., Joffre C., Vejux A., Maiza C., Bron A., Creuzot-Garcher C. and Lizard G. (2006) Analogies between atherosclerosis and age-related maculopathy: expected roles of oxysterols. J. Fr. Ophtalmol. 29, 570578.
  • Mantella R. C., Vollmer R. R., Li X. and Amico J. A. (2003) Female oxytocin-deficient mice display enhanced anxiety-related behavior. Endocrinology 144, 22912296.
  • Meaney S., Bodin K., Diczfalusy U. and Bjorkhem I. (2002) On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function. J. Lipid Res. 43, 21302135.
  • Neves S. R., Ram P. T. and Iyengar R. (2002) G protein pathways. Science 296, 16361639.
  • Olsen B. N., Schlesinger P. H., Ory D. S. and Baker N. A. (2012) Side-chain oxysterols: from cells to membranes to molecules. Biochim. Biophys. Acta 1818, 330336.
  • Ong W. Y., Kim J. H., He X., Chen P., Farooqui A. A. and Jenner A. M. (2010) Changes in brain cholesterol metabolome after excitotoxicity. Mol. Neurobiol. 41, 299313.
  • Paxinos G. and Watson C. (1996) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
  • Pehkonen P., Welter-Stahl L., Diwo J., Ryynanen J., Wienecke-Baldacchino A., Heikkinen S., Treuter E., Steffensen K. R. and Carlberg C. (2012) Genome-wide landscape of liver X receptor chromatin binding and gene regulation in human macrophages. BMC Genomics 13, 50.
  • Pierce K. L., Premont R. T. and Lefkowitz R. J. (2002) Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3, 639650.
  • Pobbe R. L., Pearson B. L., Blanchard D. C. and Blanchard R. J. (2012) Oxytocin receptor and Mecp2(308/Y) knockout mice exhibit altered expression of autism-related social behaviors. Physiol. Behav. 107, 641648.
  • Portela A. and Esteller M. (2010) Epigenetic modifications and human disease. Nat. Biotechnol. 28, 10571068.
  • Radhakrishnan A., Ikeda Y., Kwon H. J., Brown M. S. and Goldstein J. L. (2007) Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc. Natl Acad. Sci. USA 104, 65116518.
  • Robbesyn F., Salvayre R. and Negre-Salvayre A. (2004) Dual role of oxidized LDL on the NF-kappaB signaling pathway. Free Radic. Res. 38, 541551.
  • Romeo G. R. and Kazlauskas A. (2008) Oxysterol and diabetes activate STAT3 and control endothelial expression of profilin-1 via OSBP1. J. Biol. Chem. 283, 95959605.
  • Rosenbaum D. M., Rasmussen S. G. and Kobilka B. K. (2009) The structure and function of G-protein-coupled receptor. Nature 459, 356363.
  • Scantamburlo G., Hansenne M., Fuchs S., Pitchot W., Marechal P., Pequeux C., Ansseau M. and Legros J. J. (2007) Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology 32, 407410.
  • Shaywitz A. J. and Greenberg M. E. (1999) CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 68, 821861.
  • Skirboll L. R., Grace A. A., Hommer D. W., Rehfeld J., Goldstein M., Hökfelt T. and Bunney B. S. (1981) Peptide-monoamine coexistence: studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons. Neuroscience 6, 21112124.
  • Takayanagi Y., Yoshida M., Bielsky I. F. et al. (2005) Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice. Proc. Natl Acad. Sci. USA 102, 1609616101.
  • Tirado-Santiago G., Lazaro-Munoz G., Rodriguez-Gonzalez V. and Maldonado-Vlaar C. S. (2006) Microinfusions of neurotensin antagonist SR 48692 within the nucleus accumbens core impair spatial learning in rats. Behav. Neurosci. 120, 10931102.
  • Vaya J. and Schipper H. M. (2007) Oxysterols, cholesterol homeostasis, and Alzheimer disease. J. Neurochem. 102, 17271737.
  • Vejux A., Malvitte L. and Lizard G. (2008) Side effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis. Braz. J. Med. Biol. Res. 41, 545556.
  • Wilson J., Markie D. and Fitches A. (2012) Cholecystokinin system genes: associations with panic and other psychiatric disorders. J. Affect. Disord. 136, 902908.
  • Wood W. G., Igbavboa U., Rao A. M., Schroeder F. and Avdulov N. A. (1995) Cholesterol oxidation reduces Ca(2+)+MG (2+)-ATPase activity, interdigitation, and increases fluidity of brain synaptic plasma membranes. Brain Res. 683, 3642.